The objective of the procurement is to procure quick testing equipment for microbiological NAT/PCR analyses. The procurement is divided into three sub-contracts, connected to different types of samples. Sub-contract 1: Tenders are wanted for 2 identical systems/equipment for detecting influenza viruses A-RNA, Influenza virus B-RNA, SARS-CoV-2-RNA and RSV-RNA by nucleic acidamplifikation test (NAT). The two systems are intended to be placed in the Department of Medical Microbiology (AMM) and the Emergency Department. A sample volume of approx. 10,000 samples is expected per annum, in total at AMM and the Emergency Centre.  The sub-contract also includes systems/equipment for expanding capacity from 6 samples to 8 samples (Inf. A/B, RSV and SARS-CoV-2 by nucleic acidamplifikation test). Option for Bergen Regional Health Authority: The sub-contract includes an option for the delivery of equivalent quick test equipment to Helse Bergen HF. The estimated annual sample volume is 12,000 samples. Sub-contract 2: Tenders are wanted for a system/equipment for screening MRSA DNA directly from sample material for realtime PCR. A sample volume of approx. 1,200 samples is expected per annum.  Sub-contract 3: Tenders are wanted for a system/equipment for syndromeic testing for realtime PCR. The equipment shall be used for detecting nucleic acids from respiratory saws for detecting respiratory infection and nucleic acids from spinal fluid reagents for detecting meningitis/encephalitis. The annual expected sample volume is approx. 1,500 airway samples and 350 spinal fluid samples. Joint documents are available during the main competition. Documents that apply to each individual sub-contract, which shall be submitted by the tender deadline, can be found under the respective sub-contract.

LOT-0001
2025/49226
Sub-contract 1 - Quick test equipment for analyses of Inf. A/B, RSV and SARS-CoV-2.
Tenders are wanted for 2 identical systems/equipment for detecting influenza virus A-RNA, Influenza virus B-RNA, SARS-CoV-2-RNA and RSV-RNA for nucleic acidamplifikation test (NAT). The two systems are intended to be placed in the Department of Medical Microbiology (AMM) and the Emergency Department. A sample volume of approx. 10,000 samples is expected per annum, in total at AMM and the Emergency Centre.  The sub-contract also includes systems/equipment for expanding capacity from 6 samples to 8 samples (Inf. A/B, RSV and SARS-CoV-2 by nucleic acidamplifikation test). Option for Bergen Regional Health Authority: The sub-contract includes an option for the delivery of equivalent quick test equipment to Helse Bergen HF. The estimated annual sample volume is 12,000 samples. Tenderers are also requested to submit tenders for equipment dependent consumables for the equipment. The prices shall be filled in Annex 1 - Price Form, in the tab "Equipment dependent consumables", based on the stated estimated annual sample volumes. Note that the maximum value of the framework agreement can be up to 50% of the estimated consumption of consumables over the equipment ́s lifetime.

LOT-0002
2025/49227
Sub-contract 2 - Quick testing equipment for screening MRSA..
Tenders are wanted for systems/equipment for screening MRSA-DNA directly from sample material for realtime PCR. A sample volume of approx. 1,200 samples is expected per annum. Tenderers are also requested to submit tenders for equipment dependent consumables for the equipment. The prices shall be filled in Annex 1.2 - Price Form in the tab "Equipment dependent consumables", based on the stated estimated annual sample volumes. Note that the maximum value of the framework agreement can be up to 50% of the estimated consumption of consumables over the equipment ́s lifetime.

LOT-0003
2025/49228
Sub-contract 3 - Quick testing equipment for syndrome testing spinal and airway samples..
Sub-contract 3: Tenders are wanted for a system/equipment for syndromeic testing for realtime PCR. The equipment shall be used for detecting nucleic acids from respiratory saws for detecting respiratory infection and nucleic acids from spinal fluid reagents for detecting meningitis/encephalitis. The annual expected sample volume is approx. 1,500 airway samples and 350 spinal fluid samples.